Roivant Sciences (ROIV) News Today $11.49 +0.18 (+1.59%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Roivant Sciences Ltd. (NASDAQ:ROIV) Given Consensus Recommendation of "Moderate Buy" by AnalystsNovember 19 at 4:17 AM | americanbankingnews.com'I'm One Of You' – How 'Anti-Woke' Warrior Vivek Ramaswamy Became A Billionaire At Only 38November 19 at 3:51 AM | benzinga.comPrincipal Financial Group Inc. Sells 145,614 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)Principal Financial Group Inc. lowered its stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 12.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,009,758 shares of the company's stock after sellingNovember 18 at 3:22 AM | marketbeat.comVivek Ramaswamy's Net Worth Is 9 Figures—See How the DOGE Co-Lead Made His MillionsNovember 15, 2024 | msn.comRoivant Sciences (NASDAQ:ROIV) Earns "Buy" Rating from HC WainwrightNovember 15, 2024 | americanbankingnews.com[Latest] Vivek Ramaswamy Net Worth 2024: Salary, Net Worth in Rupees (INR), IncomeNovember 14, 2024 | msn.comPositive Outlook on Roivant Sciences: Buy Rating Justified by Strong Cash Position and Promising Pipeline DevelopmentsNovember 14, 2024 | markets.businessinsider.comRoivant Sciences Ltd. (NASDAQ:ROIV) Given Average Recommendation of "Moderate Buy" by AnalystsRoivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) has received an average rating of "Moderate Buy" from the nine brokerages that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. TNovember 14, 2024 | marketbeat.comWho is Vivek Ramaswamy? Know about his early life, education, and role as head of the new "Department of Government Efficiency" (DOGE)November 13, 2024 | msn.comVarmX Announces Appointment of John Glasspool as CEONovember 12, 2024 | finance.yahoo.comRoivant Sciences Posts Mixed Q2November 12, 2024 | fool.comRoivant Sciences Ltd. (ROIV) Q2 2024 Earnings Call TranscriptNovember 12, 2024 | seekingalpha.comRoivant Sciences Ltd. 2024 Q2 - Results - Earnings Call PresentationNovember 12, 2024 | seekingalpha.comRoivant Sciences (ROIV) Receives a Buy from TD CowenNovember 9, 2024 | markets.businessinsider.comRoivant Sciences (ROIV) Scheduled to Post Earnings on TuesdayRoivant Sciences (NASDAQ:ROIV) will be releasing earnings before the market opens on Tuesday, November 12, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=642294)November 5, 2024 | marketbeat.comOrganon: FDA Extends Vtama Atopic-Dermatitis Review to MarchNovember 5, 2024 | marketwatch.comRoivant Sciences Ltd. (NASDAQ:ROIV) Shares Bought by Impax Asset Management Group plcImpax Asset Management Group plc grew its stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 25.0% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 2,000,000 shares of the company's stock after buying an additional 400,000 shares during the quarter. ImNovember 5, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Sells 115,694 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)Allspring Global Investments Holdings LLC reduced its stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 88.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,937 shares of the coNovember 4, 2024 | marketbeat.comRoivant to Report Financial Results for the Second Quarter Ended September 30, 2024 and Provide Business Update on Tuesday, November 12, 2024October 29, 2024 | globenewswire.comChina Universal Asset Management Co. Ltd. Boosts Position in Roivant Sciences Ltd. (NASDAQ:ROIV)China Universal Asset Management Co. Ltd. raised its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 63.9% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 142,234 shares of the company's stock after purchasing an additional 55,445 sharesOctober 29, 2024 | marketbeat.comOrganon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%October 28, 2024 | globenewswire.comOptions Exercise: Eric Venker At Roivant Sciences Realizes $782KOctober 23, 2024 | benzinga.comAt Roivant Sciences, Eric Venker Chooses To Exercise Options, Resulting In $782KOctober 23, 2024 | benzinga.comRoivant Sciences Ltd. (NASDAQ:ROIV) COO Eric Venker Sells 100,000 SharesOctober 23, 2024 | insidertrades.comLeerink maintient sa recommandation Surperformance sur Roivant avec un objectif de cours inchangéOctober 22, 2024 | fr.investing.comRoivant Sciences (ROIV) Gets a Buy from Leerink PartnersOctober 22, 2024 | markets.businessinsider.comRoivant Sciences Ltd. (NASDAQ:ROIV) Receives Consensus Rating of "Moderate Buy" from AnalystsShares of Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) have been given an average recommendation of "Moderate Buy" by the ten brokerages that are covering the firm, Marketbeat reports. One analyst has rated the stock with a hold recommendation and nine have given a buy recommendation toOctober 20, 2024 | marketbeat.comPrice Over Earnings Overview: Roivant SciencesOctober 18, 2024 | benzinga.comRoivant Sciences (ROIV): High-Growth UK Stock with Innovative Drug Development ModelOctober 17, 2024 | msn.comJPMorgan réitère son objectif de cours et sa recommandation surpondérer pour les actions de Roivant SciencesOctober 16, 2024 | fr.investing.comExchange Traded Concepts LLC Purchases Shares of 196,480 Roivant Sciences Ltd. (NASDAQ:ROIV)Exchange Traded Concepts LLC purchased a new stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 196,480 shares of the company's stock, valued at approximatelOctober 15, 2024 | marketbeat.comDimensional Fund Advisors LP Makes New Investment in Roivant Sciences Ltd. (NASDAQ:ROIV)Dimensional Fund Advisors LP acquired a new stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 252,721 shares of the comOctober 11, 2024 | marketbeat.comHandelsbanken Fonder AB Has $2.21 Million Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)Handelsbanken Fonder AB boosted its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 67.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 191,409 shares of the company's stock aOctober 10, 2024 | marketbeat.comThe Manufacturers Life Insurance Company Reduces Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)The Manufacturers Life Insurance Company cut its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 19.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 321,959 shares of the company'sOctober 9, 2024 | marketbeat.comAlgert Global LLC Sells 102,329 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)Algert Global LLC cut its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 68.8% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 46,331 shares of the company's stock after sellOctober 8, 2024 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Shares Acquired by Clearbridge Investments LLCClearbridge Investments LLC boosted its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 51.3% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,860,536 shares of the company's stock after pOctober 5, 2024 | marketbeat.comRoivant Sciences (NASDAQ:ROIV) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comRoivant Sciences (NASDAQ:ROIV) Stock, Insider Trading ActivityOctober 4, 2024 | benzinga.comRoivant Sciences (NASDAQ:ROIV) Stock, Short Interest ReportOctober 4, 2024 | benzinga.comPoint72 Asset Management L.P. Buys 185,226 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)Point72 Asset Management L.P. grew its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 40.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 647,126 shares of the company's stock after purchasinOctober 2, 2024 | marketbeat.comIs Roivant Sciences Ltd. (ROIV) a Strong Buy Amid Positive Clinical Trials and Strategic Partnerships?October 1, 2024 | finance.yahoo.comIs Roivant Sciences Ltd. (ROIV) the Best Stock Under $15 To Buy Now?October 1, 2024 | finance.yahoo.comMarshall Wace LLP Boosts Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV)Marshall Wace LLP lifted its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 1,221.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 714,760 shares of the company's stock after purchasing an aOctober 1, 2024 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Shares Purchased by Pacer Advisors Inc.Pacer Advisors Inc. raised its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 1,287.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 55,500 shares of the company's stock after acquiring an additional 51,5September 29, 2024 | marketbeat.comKeith S. Manchester Sells 368,052 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) StockSeptember 27, 2024 | insidertrades.comDME Capital Management LP Increases Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)DME Capital Management LP grew its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 14.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,810,960 shares of the company's stock afteSeptember 26, 2024 | marketbeat.comAffinity Asset Advisors LLC Sells 148,413 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)Affinity Asset Advisors LLC cut its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 29.7% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 351,587 shares of the company's stSeptember 25, 2024 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) CAO Sells $2,972,500.00 in StockSeptember 25, 2024 | insidertrades.comRoivant Sciences Ltd. (NASDAQ:ROIV) Given Average Rating of "Moderate Buy" by AnalystsShares of Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) have received an average rating of "Moderate Buy" from the ten brokerages that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and nine have given a buy recomSeptember 25, 2024 | marketbeat.comRoivant Sciences Target of Unusually Large Options Trading (NASDAQ:ROIV)Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) was the recipient of unusually large options trading activity on Tuesday. Stock traders bought 5,202 call options on the company. This is an increase of approximately 128% compared to the typical volume of 2,278 call options.September 24, 2024 | marketbeat.com Get Roivant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ROIV and its competitors with MarketBeat's FREE daily newsletter. Email Address Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW ROIV Media Mentions By Week ROIV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ROIV News Sentiment▼0.310.45▲Average Medical News Sentiment ROIV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ROIV Articles This Week▼75▲ROIV Articles Average Week Get Roivant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ROIV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BNTX News Today TEVA News Today BGNE News Today VTRS News Today SMMT News Today MRNA News Today GMAB News Today RDY News Today PCVX News Today CTLT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ROIV) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roivant Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Roivant Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
